Intravenous immunoglobulin G treatment increases live birth rate in women with recurrent miscarriage and modulates regulatory and exhausted regulatory T cells frequency and function. Issue 4 (16th October 2018)

• Record Type: Journal Article
• Authors: Jafarzadeh, Sara; Ahmadi, Majid; Dolati, Sanam; Aghebati‐Maleki, Leili; Eghbal‐Fard, Shadi; Kamrani, Amin; Behrad, Behboud; Roshangar, Leila; Jadidi‐Niaragh, Farhad; Yousefi, Bahman; Mehdipour, Mahdi; Farzadi, Laya; Yousefi, Mehdi
• Is Part Of: Journal of cellular biochemistry. Volume 120:Issue 4(2019)
• Page Start: 5424
• Page End: 5434
• Publication Date: 2018-10-16
• Subjects: exhausted T cell -- immunoglobulin -- intravenous immunoglobulin G (IVIG) -- recurrent miscarriage (RM) -- regulatory T‐cell (Treg); Cytochemistry -- Periodicals; 572
• DOI: 10.1002/jcb.27821
• Languages: English
• ISSNs: 0730-2312

Abstract

Abstract: Exhausted T cells and regulatory T (Treg) cells have been recently proposed to be new risk factors for recurrent miscarriage (RM). Intravenous immunoglobulin G (IVIG) treatment reported to modulate various immune cells. In this study, the effects of IVIG on the frequency and function of exhausted T cells, exhausted Tregs, and Treg cells, as well as pregnancy outcome in women with unexplained RM (URM), were investigated. Ninety‐four pregnant women with RM were enrolled. At the time of positive pregnancy, blood samples were drawn. Forty‐four patients with URM were included as IVIG receiving treated group and received 400 mg/kg of IVIG and the rest fifty patients were considered as a control group and received no IVIG administration. IVIG was given intravenously every 4 weeks during 32 weeks of gestation. Blood samples of patients were collected after the latest administration. Exhausted T cells, exhausted Tregs, and Treg cells were evaluated pre‐ and posttreatment in both groups. IVIG induced a significant decrease in the frequency of exhausted Tregs population and function as well as a significant increase in Treg cells population, however, IVIG failed to affect population and the function of exhausted T cells. Pregnancy outcome was successful in IVIG treated women (86.3%) and were significantly different ( P = 0.0006) in compared with the untreated URM subjects (42%). Therefore, employing of IVIG increases Treg cells and diminishes exhausted Tregs responses in RM patients with cellular immune anomalies throughout the pregnancy. Immunemodulatory effects of IVIG are probably associated with successful pregnancy outcome.